Purdue Pharma won court approval to exit bankruptcy, capping six years of legal wrangling over a multibillion-dollar settlement and liability releases for the opioid manufacturer’s Sackler family owners.

Judge Sean H. Lane said he will sign off on Purdue’s Chapter 11 plan during a hearing Friday in the U.S. Bankruptcy Court for the Southern District of New York. The plan contemplates an estimated $7.4 billion in payments to address nationwide harm caused by the mass marketing and production of addictive painkillers.

The judge will issue his full, detailed ruling in court next week.

The plan was negotiated for more than a year following the U.S. Supreme Court’s June 2024 decision overturning a prior iteration that provided a blanket legal liability shield in favor of the Sackler family f

See Full Page